{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:18:31Z","timestamp":1732598311418,"version":"3.28.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trim.2024.102133","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:56:00Z","timestamp":1726847760000},"page":"102133","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Post-transplantation monitoring and quantitation of microparticles in allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"87","author":[{"given":"A.","family":"Xagorari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Iskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dimosthenous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bougiouklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Sakellari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2024.102133_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2024.102133_bb0010","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.trim.2024.102133_bb0015","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1084\/jem.20161721","article-title":"Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation","volume":"241","author":"Kollek","year":"2017","journal-title":"JEM"},{"key":"10.1016\/j.trim.2024.102133_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00281-010-0239-3","article-title":"Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis","volume":"3","author":"Morel","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.trim.2024.102133_bb0025","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1538-7836.2003.00309.x","article-title":"Cellular microparticles: what are they bad or good for?","volume":"1","author":"Freyssinet","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.trim.2024.102133_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/01.HYP.0000231507.00962.b5","article-title":"Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease","volume":"48","author":"Boulanger","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.trim.2024.102133_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exphem.2019.11.001","article-title":"Identification of miRNAs from stem cell derived microparticles in umbilical cord blood","volume":"80","author":"Xagorari","year":"2019","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.trim.2024.102133_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116812","article-title":"Detection and quantification of microparticles from different cellular lineages using flow cytometry. evaluation of the impact of secreted phospholipase A2 on microparticle assessment","volume":"10","author":"Rousseau","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2024.102133_bb0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/VHRM.S955","article-title":"Characterizing blood microparticles:technical aspects and challenges","volume":"4","author":"Shet","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.trim.2024.102133_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/08916930601061538","article-title":"Microparticles as mediators of cellular cross-talk in inflammatory disease","volume":"39","author":"Distler","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.trim.2024.102133_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bmt.1705150","article-title":"Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-derived microparticles in TMA\/TTP","volume":"36","author":"Nomura","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.trim.2024.102133_bb0060","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3109\/10428194.2015.1028054","volume":"56","author":"Sakellari","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.trim.2024.102133_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1703663","article-title":"Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Pihusch","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2024.102133_bb0070","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cyto.a.20886","article-title":"Flow cytometric analysis of circulating microparticles in plasma","volume":"77","author":"Orozco","year":"2010","journal-title":"Cytometry A"},{"issue":"4","key":"10.1016\/j.trim.2024.102133_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15313","article-title":"Effects of CD34+ cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation","volume":"38","author":"Oyama","year":"2024","journal-title":"Clin. Transpl."},{"issue":"181","key":"10.1016\/j.trim.2024.102133_bb0080","article-title":"Effect of CD34+ cell dose on the outcomes of allogeneic stem cell transplantation with post-transplantation cyclophosphamide","volume":"29","author":"Pedraza","year":"2023","journal-title":"Transpl. Cell. Therapy."},{"issue":"2","key":"10.1016\/j.trim.2024.102133_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jtct.2021.11.004","article-title":"Association of CD34 cell dose with 5-year overall survival after peripheral blood allogeneic hematopoietic cell transplantation in adults with hematologic malignancies","volume":"28","author":"Gauntner","year":"2022","journal-title":"Transpl. Cell. Therapy."},{"key":"10.1016\/j.trim.2024.102133_bb0090","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00277-013-1847-5","article-title":"Predictive factors for rapid neutrophil and platelet engraftment after allogenic peripheral blood stem cell transplantation in patients with acute leukemia","volume":"92","author":"Lee","year":"2013","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.trim.2024.102133_bb0095","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/bmt.2015.7","article-title":"Reduced-intensity conditioned allogeneic SCT in adults with AML","volume":"50","author":"Reshef","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.trim.2024.102133_bb0100","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.trim.2024.102133_bb0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","article-title":"Risk factors for acute graft-versus-host disease","volume":"67","author":"Gale","year":"1987","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.trim.2024.102133_bb0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trim.2024.102133_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13537","article-title":"The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease","volume":"33","author":"Svenberg","year":"2019","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2024.102133_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/TP.0b013e3181622e36","article-title":"B-cell concentration in the apheretic product predicts acute graft-versus-host disease and treatment-related mortality of allogeneic peripheral blood stem cell transplantation","volume":"85","author":"Iori","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2024.102133_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01534","article-title":"Cytotoxicity of donor natural killer cells to Allo-reactive T cells are related with acute graft-vs.-host-disease following allogeneic stem cell transplantation","volume":"11","author":"Sheng","year":"2020","journal-title":"Front. Immunol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327424001497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T03:54:09Z","timestamp":1732593249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327424001497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"alternative-id":["S0966327424001497"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2024.102133","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-transplantation monitoring and quantitation of microparticles in allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2024.102133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102133"}}